EBioMedicine (Apr 2021)

In response to the Letter to the Editor by Romach et al. re our publication “Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels”

  • H. Mohan,
  • M. Guzman Lenis,
  • E.Y. Laurette,
  • O. Tejada,
  • T. Sanghvi,
  • K.-Y. Leung,
  • L.S. Cahill,
  • J.G. Sled,
  • P. Delgado-Olguín,
  • N.D.E. Greene,
  • A.J. Copp,
  • L. Serghides

Journal volume & issue
Vol. 66
p. 103334

Abstract

Read online

No abstracts available.